H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $15.00 price target on Lisata Therapeutics, Inc (NASDAQ: LSTA).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)